Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Qiang Fu to Osteoprotegerin

This is a "connection" page, showing publications Qiang Fu has written about Osteoprotegerin.

 
Connection Strength
 
 
 
0.395
 
  1. Fu Q, Bustamante-Gomez NC, Reyes-Pardo H, Gubrij I, Escalona-Vargas D, Thostenson JD, Palmieri M, Goellner JJ, Nookaew I, Barnes CL, Stambough JB, Ambrogini E, O'Brien CA. Reduced osteoprotegerin expression by osteocytes may contribute to rebound resorption after denosumab discontinuation. JCI Insight. 2023 09 22; 8(18).
    View in: PubMed
    Score: 0.225
  2. Deng L, Peng Y, Wu Y, Yang M, Ding Y, Chen Q, Fu Q. Tissue distribution of emulsified ?-tocotrienol and its long-term biological effects after subcutaneous administration. Lipids Health Dis. 2014 Apr 09; 13:66.
    View in: PubMed
    Score: 0.117
  3. Fu Q, Jilka RL, Manolagas SC, O'Brien CA. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem. 2002 Dec 13; 277(50):48868-75.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.